LeMaitre Vascular

LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. The company is listed on NASDAQ.
Type
Public
HQ
Burlington, US
Founded
1983
Size (employees)
339 (est)
LeMaitre Vascular was founded in 1983 and is headquartered in Burlington, US

LeMaitre Vascular Office Locations

LeMaitre Vascular has offices in Burlington, Inzell, Chiyoda, Mississauga and in 4 other locations
Burlington, US (HQ)
63 Second Ave
North Melbourne, AU
36 Munster Terrace
San Giuliano Milanese, IT
86 Viale Leone Tolstoj
Madrid, ES
Plaza de España
Mississauga, CA
608 5915 Airport Rd
Inzell, DE
Otto-Volger-Str. 5 a/b 65843 Sulzbach/Ts

LeMaitre Vascular Metrics

LeMaitre Vascular Financial Metrics

Revenue (2016)

$89.2 m

Revenue growth (2015-16), %

14%

Gross profit

$62.9 m

Gross profit margin (2016), %

71%

Net income (2016)

$10.6 m

Market capitalization (21-Mar-2017)

$449 m

Closing share price (21-Mar-2017)

$24

Cash (31-Dec-2016)

$24.3 m
LeMaitre Vascular's current market capitalization is $449 m.
LeMaitre Vascular's revenue was reported to be $89.2 m in 2016
FY, 2013FY, 2014FY, 2015Y, 2016

Revenue

$64.5 m$71.1 m$78.4 m$89.2 m

Revenue growth, %

10%10%14%

Cost of goods sold

$19.4 m$22.7 m$24.2 m$26.2 m

Gross profit

$45.1 m$48.4 m$54.2 m$62.9 m

Gross profit Margin, %

70%68%69%71%

Operating expense total

$40.6 m$42.1 m$42.7 m$46.6 m

EBIT

$4.5 m$6.3 m$11.5 m$16.3 m

EBIT margin, %

7%9%15%18%

Interest expense

$12 k$5 k$5 k$14 k

Interest income

$4 k$1 k$13 k$81 k

Pre tax profit

$4.3 m$6.3 m$11.4 m$16.2 m

Income tax expense

$1.1 m$2.4 m$3.7 m$5.7 m

Net Income

$3.2 m$3.9 m$7.8 m$10.6 m
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$14.7 m$18.7 m$27.5 m$24.3 m

Accounts Receivable

Inventories

$3.2 m$2.4 m$3.6 m$2 m

Current Assets

$41.7 m$48.6 m$58.2 m$59 m

PP&E

$5.8 m$6.9 m$7 m$8 m

Goodwill

$15 m$17.3 m$17.8 m$23.4 m

Total Assets

$70.5 m$81.5 m$90.7 m$101.9 m

Accounts Payable

$1.2 m$1.1 m$1.4 m$1.2 m

Current Liabilities

$10.2 m$10 m$10.4 m$10.5 m

Additional Paid-in Capital

$65.4 m$75.4 m$82.1 m$85.4 m

Retained Earnings

($667 k)$3.2 m$8.2 m$15.3 m

Total Equity

$56.6 m$68.2 m$77.9 m$87.5 m

Financial Leverage

1.2 x1.2 x1.2 x1.2 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$3.2 m$3.9 m$7.8 m$10.6 m

Depreciation and Amortization

$2.8 m$3.3 m$3.4 m$3.6 m

Accounts Receivable

($1.2 m)($654 k)($1.9 m)($922 k)

Inventories

($2.2 m)($2.7 m)$608 k

Accounts Payable

$861 k($1.1 m)$2.6 m($103 k)

Cash From Operating Activities

$5.4 m$5.5 m$11.4 m$16.9 m

Purchases of PP&E

($2.7 m)($1.2 m)($2.3 m)($2.8 m)

Cash From Investing Activities

($6.2 m)($7.7 m)($3.5 m)($17.2 m)

Long-term Borrowings

($1.1 m)($1.1 m)($1.1 m)

LeMaitre Vascular Market Value History

LeMaitre Vascular Online Presence

LeMaitre Vascular Company Life

You may also be interested in